Amicable Settlement Underscores Strength of Bonguard's Intellectual Property Portfolio and Commitment to Protecting Innovation

PHOENIX, Sept. 8, 2026 /PRNewswire/ -- Bonguard Naturals today announced the successful and amicable resolution of a patent matter protecting the intellectual property behind Nixodine®, a 6-methyl technology platform the company believes has the potential to fundamentally reshape its industry.

The resolution represents an important validation of Bonguard Naturals' strategy to build, protect, and commercialize a robust intellectual property portfolio around a new generation of 6-methyl products. It also affirms the company's commitment to defending those rights while fostering constructive relationships within the industry.

Ready Mix Naturals, LLC, owner of the patent portfolio covering innovative 6-methyl products sold under the Nixodine® brand, previously filed a federal patent action concerning certain products. The matter has now been resolved through a cooperative settlement that leaves the Nixodine® patent portfolio fully intact.

From the outset, LBC Products demonstrated a high degree of professionalism and compliance with Ready Mix's requests. The parties worked constructively to reach an agreement that respects the underlying intellectual property while providing a clear, authorized path forward. Bonguard Naturals appreciates LBC's cooperative approach throughout the process.

THE MESSAGE TO THE MARKETPLACE IS CLEAR:

THESE PATENTS MATTER. THEY ARE BEING PROTECTED. AND BONGUARD NATURALS REMAINS COMMITTED TO SAFEGUARDING THE INNOVATION BEHIND NIXODINE®.

Protecting Technology With the Potential to Define an Industry

The patents at the center of the matter form part of the intellectual property foundation supporting Nixodine®, an emerging 6-methyl product platform that Bonguard Naturals believes is poised to become an important force in the evolution of the industry.

As companies race to develop the next generation of products in this rapidly changing marketplace, proprietary technology — and the patents protecting it — can determine who ultimately leads a new category. Bonguard Naturals intends to be one of those leaders.

"We believe Nixodine® represents an extraordinary technological and commercial opportunity, and protecting the intellectual property behind it is one of our highest priorities," said Rick Avila, co-founder of Bonguard Naturals. "These patents protect innovation that we believe has the potential to transform this industry. We invested in developing it, we invested in protecting it, and when necessary, we will invest in enforcing it."

"This resolution should remove any doubt about how seriously we take our intellectual property," Avila continued. "At the same time, we value constructive dialogue and are pleased that this matter was resolved in a spirit of cooperation."

Building an Authorized Ecosystem

The agreement also highlights the commercial strength of the Nixodine® intellectual property strategy. It establishes a clear framework under which future participation in the 6-methyl space can occur through authorized channels that respect the underlying patents and brand standards.

Bonguard Naturals is not merely building a brand. It is building an intellectual-property-protected commercial ecosystem around technology it believes could help define the next era of the industry.

Four U.S. Patents — And A Broader Intellectual Property Portfolio

The matter involved U.S. Patent Nos. 11,964,958; 12,358,888; 12,358,889; and 12,497,381.

The broader portfolio also encompasses certain related divisional, continuations, continuations-in-part, reissues and reexaminations. Together, these intellectual property rights form an increasingly important protective framework around Nixodine® technology.

A Clear Signal to the Marketplace

Bonguard Naturals intends to continue monitoring the marketplace for potential infringement and taking appropriate action to protect its intellectual property when necessary.

For manufacturers, distributors and brands operating in the 6-methyl space, this resolution establishes an important precedent: the company is attentive to the market, understands the value of its patents, and is prepared to protect them — preferably through constructive engagement whenever possible.

"In emerging industries, there is often a period where companies assume new technology is simply available for anyone to copy," Avila said. "That is not the case here. We have built meaningful intellectual property around Nixodine®, and we intend to defend it. We also welcome those who wish to participate through authorized channels."

As Nixodine® moves toward broader commercialization, Bonguard Naturals intends to continue investing in innovation, expanding its intellectual property position, and protecting the technology it believes can help transform the industry.

About Bonguard Naturals

Bonguard Naturals is the company behind Nixodine®, an innovative 6-methyl product platform supported by a growing intellectual property portfolio. The company is focused on developing, protecting and commercializing proprietary technology while building an authorized commercial ecosystem designed to safeguard innovation, product integrity and the Nixodine® brand.

SOURCE Bonguard Naturals

Share this article